WASHINGTON (Reuters) - Influenza viruses are quickly evolving resistance to the few drugs on the market that fight them, but there are weaknesses that could be exploited, experts told a conference on Tuesday.Flu specialists say the need for better flu-fighting drugs has always been clear. Ordinary, seasonal influenza kills 250,000 to 500,000 people globally every year.
